Talk:Protease inhibitor (pharmacology)

From Wikipedia, the free encyclopedia

	Protease inhibitor (pharmacology) is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome.
Start	This article has been rated as Start-Class on the quality scale.
Top	This article has been rated as top-importance for this Project's importance scale.

	This article is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at the doctor's mess.
Stub	This page has been rated as Stub-Class on the quality assessment scale
Mid	This article has been rated as Mid-importance on the importance assessment scale

[edit] In

"In all cases, patents remain in force until 2010 or beyond." This comment appears in two articles I've seen so far. What does it mean? Maury 15:35, 5 January 2007 (UTC)

This is a reference to United States patent law. The short explanation is that when a pharmaceutical company develops a new drug, it has the exclusive right to produce and sell it in the US for so many years. I think it's fifteen. After that, the patent enters the public domain and anyone can look up the patent and make a generic drug to sell using the original company's ideas. However, the patent stays "on the books but no longer in force" to prevent fraud. The author is trying to say that there won't be generic versions of any of these drugs until at least 2010. Money for a while, bragging rights forever, that's US patent law.

The exception is that the government has the right to interfere with patents if the drug was developed in whole or in part with the use of public funds (grants). That was the big deal about Norvir in 2003.

Here's some more detail and probably more accuracy:

http://people.howstuffworks.com/patent.htm

Darkfrog24 17:23, 9 January 2007 (UTC)